uniface wrote:The UN has halted a measles vaccination campaign in northern Syria after at least 15 children died after receiving shots, the UN Children's Fund (UNICEF) and World Health Organization (WHO) confirmed in a joint statement.
"UNICEF and WHO have been shocked and saddened to learn of the deaths of at least 15 young children in Idlib, Syria," the statement said. "The deaths of the children occurred in areas where a measles immunization campaign had been under way." The children were all under the age of two, Reuters reported, citing aid workers.
Around one hour after being given a second round of the measles vaccine in Idlib on Tuesday, the children demonstrated signs of "severe allergic shock," said Abdullah Ajaj, a physician administering the vaccinations at a medical center in Jarjanaz, according to AP. The second round of vaccinations began in Idlib and Deir Ezzour on Monday. Following the vaccine, some of the children's bodies swelled and they suffocated to death.
http://www.sott.net/article/316541-15-S ... n-campaign
Other reports give higher numbers of deaths.
Considering that this tragedy happened 18 months ago you might imagine that the web site wouild have been aware of a later Reuters bulletin .
The U.S. public is largely unaware that manufacturers of vaccines have been given legal immunity from being prosecuted in civil court for vaccine injuries and deaths, since 1986. If someone is injured or killed by a vaccine, they have to sue the U.S. Government in a special “vaccine court.”
The Department of Justice issues quarterly reports on claims and settlements, and one can search for specific vaccines settlements at the United States Federal Courts website. A search here for “measles” returns a result of 111 claims settled for the MMR vaccine since 2004.
The court ruled 6 to 2 that going before a special tribunal set up by Congress is the only way parents can be compensated for the negative side effects that in rare instances accompany vaccinations.
The majority said that Congress found such a system necessary to ensure that vaccines remain readily available, and that federal regulators are in the best position to decide whether vaccines are safe and properly designed.
The National Childhood Vaccine Injury Act of 1986 "reflects a sensible choice to leave complex epidemiological judgments about vaccine design to the FDA and the National Vaccine Program rather than juries," Justice Antonin Scalia wrote, referring to the Food and Drug Administration.
The 1986 federal law said that all such claims must first go to a special tribunal commonly called the "Vaccine Court." The program has awarded nearly $2 billion for vaccine-injury claims in nearly 2,500 cases since 1989. It is funded by a tax on immunizations.
But the tribunal ruled against the Bruesewitzes, saying they had not proved that the vaccine harmed Hannah, who will need lifelong care.
I worked at the U.S. Environmental Protection Agency (EPA) for 25 years. I spent most of that time at the Office of Pesticide Programs. I was astonished by EPA’s nasty habit of covering up for the industry and its friends in Congress and the White House. My memos reminded senior managers that the EPA was fighting the wrong battles. I objected most strenuously to the EPA approval of neurotoxins in nylon microcapsules that decimated honeybees. EPA officials branded me “not a team player.”
The widespread use of deadly neurotoxins was in full swing as early as in the 1970s. In addition to killing bees and other beneficial insects, the encapsulated parathion caused various degrees of neurological damage and quite possibly, death to small and large mammals, terrestrial and water invertebrates and birds—even at rates of just a pound of poison per acre. The gizzards of most birds would grind down and rupture the nerve poison microcapsules, causing crippling disease or death.
Some EPA ecologists also protested the use of nerve poisons in farming. They knew that bees would continue to die from the encapsulated parathion because the “registrant,” the chemical company that owned the encapsulated parathion, had persuaded the EPA to approve the spraying of the company’s product during the spring bloom, when all pollinating insects would be out foraging for nectar and pollen. The ecologists also warned the killing of pollinators would be environmentally disastrous and would have adverse effects in food production. After all, honeybees pollinate enough fruits and vegetable making up about a third of what we eat.
The Carter EPA ignored the ecologists. Instead, it permitted the selling of the time-release parathion gas for use on an even wider array of produce, from artichokes, cabbages and potatoes to wheat, soybeans, apples and pears. The move dramatically raised the chemical exposure of both bees and the American people.
The evidence could not have been clearer. In 1979, an EPA scientist discovered how to stain parathion microcapsules so they could be identified in honey and pollen. Sure enough, on testing on a bee colony on the field, he found microcapsules in the queen bee’s gut and honey.
Predictably, this scientist’s discovery and talent went nowhere. He neither published his research nor continued with his honeybee investigations. Instead, he was forced to become a paper pusher at EPA headquarters while the agency’s top pesticide managers made sure that his laboratory would no longer be used for research threatening to industry.
As with so many EPA moves, this was done to keep bad news about nerve gas pesticides secret. It was evident to me that the EPA was not protecting our health but the profits of the industry—neurotoxins or no neurotoxins.
Forty years after EPA first began approving neurotoxins enclosed in microscopic spheres, the same lethal tradition remains in place with the neonicotinoids. These German-made neurotoxins disrupt the immune system of animals. Farmers have been buying them since 2003 to “treat” corn and other major crop seeds. Plants (such as corn) grown from these soaked seeds become toxic at fantastically small amounts to any insect touching or eating them.
Like the microencapsulated parathion, neonicotinoids kill outright or cripple the honeybees. Poisoned worker bees neglect to take care the eggs and feed the larvae. A bee’s navigational abilities break down. The result, according to Vera Krischik, professor of entomology at the University of Minnesota, is that honeybees “can’t remember who they are or where to go.”
This cause and effect between the nicotine-based insecticides and the near obliteration of honeybees explains the fury of the USDA. Imagine Americans discovering we are killing honeybees with neurotoxins. Even USDA scientists are raising red flags.
Like the EPA, the USDA cannot afford to offend the lords of agribusiness. But fortunately, USDA bee scientists are finally siding with honeybees, the integrity of science and the survival of our food and agriculture.
It’s obvious to me we need to protect Jonathan Lundgren, Jeffery Pettis and other whistleblowers throughout the government. They are our first line of defense against unscrupulous companies and purchased politicians who lose no sleep over the poisoning of honeybees and countless other animals.
The deeper problem is that much of cancer research in the lab—maybe even most of it—simply can’t be trusted. The data are corrupt. The findings are unstable. The science doesn’t work.
In other words, we face a replication crisis in the field of biomedicine, not unlike the one we’ve seen in psychology but with far more dire implications. Sloppy data analysis, contaminated lab materials, and poor experimental design all contribute to the problem. Last summer, Leonard P. Freedman, a scientist who worked for years in both academia and big pharma, published a paper with two colleagues on “the economics of reproducibility in preclinical research.” After reviewing the estimated prevalence of each of these flaws and fault-lines in biomedical literature, Freedman and his co-authors guessed that fully half of all results rest on shaky ground, and might not be replicable in other labs. These cancer studies don’t merely fail to find a cure; they might not offer any useful data whatsoever. Given current U.S. spending habits, the resulting waste amounts to more than $28 billion.
When cancer research does get tested, it’s almost always by a private research lab. Pharmaceutical and biotech businesses have the money and incentive to proceed—but these companies mostly keep their findings to themselves. (That’s another break in the feedback loop of self-correction.) In 2012, the former head of cancer research at Amgen, Glenn Begley, brought wide attention to this issue when he decided to go public with his findings in a piece for Nature. Over a 10-year stretch, he said, Amgen’s scientists had tried to replicate the findings of 53 “landmark” studies in cancer biology. Just six of them came up with positive results.
Begley blames these failures on some systematic problems in the literature, not just in cancer research but all of biomedicine. He says that preclinical work—the basic science often done by government-funded, academic scientists—tends to be quite slipshod. Investigators fail to use controls; or they don’t blind themselves to study groups; or they selectively report their data; or they skip important steps, such as testing their reagents.
Begley’s broadside came as no surprise to those in the industry. In 2011, a team from Bayer had reported that only 20 to 25 percent of the studies they tried to reproduce came to results “completely in line” with those of the original publications. There’s even a rule of thumb among venture capitalists, the authors noted, that at least half of published studies, even those from the very best journals, will not work out the same when conducted in an industrial lab.
The former head of the FDA, Margaret Hamburg, used the federal agency to run a massive conspiracy of racketeering and fraud in order to generate millions of dollars in drug company profits for her husband's hedge fund firm, alleges a damning lawsuit filed in the United States District Court for the District of Columbia.
The lawsuit alleges that while acting as FDA commissioner, Margaret Hamburg engaged in a wide-ranging conspiracy to approve an extremely dangerous drug known to cause severe (and even deadly) side effects, in order to financially benefit her husband's hedge fund which held very large financial positions in Johnson & Johnson, makers of the drug. "Defendants, each and every one of them, operated a criminal conspiracy at least between the years 2009 to 2015 to fraudulently suppress warnings about the devastating effects of Levaquin," says the complaint.
"This Amended Complaint sets forth allegations that involve a conspiracy by Defendants, each and every one of them, to reap large financial returns by failing to disclose to Plaintiffs and the public at large the full extent of the devastating, life-threatening, and deadly effects of a highly dangerous pharmaceutical drug named Levaquin," reads the opening of the lawsuit. The conspiracy complaint also alleges that over 5,000 people died as a result of Hamburg's conspiracy cover-up at the FDA:
Once confirmed as FDA Commissioner, Dr. Margaret A. Hamburg acted as the instrumentality that all Defendants used to perpetrate their conspiracy and racketeering enterprise by having her act illegally and outside the scope of her authority as FDA Commissioner to suppress material information to Plaintiffs and the public that Levaquin was inherently dangerous and in fact, deadly. Had this information been disclosed to Plaintiffs and the public at large, her and her husband's financial gain and net worth would have plummeted, since Dr. Margaret A. Hamburg's husband, Peter F. Brown, reaped and continues to reap huge financial gain as a result of Renaissance Technologies, L.L.C.'s holdings of Johnson & Johnson stock.
Dr. Margaret A. Hamburg was nominated as a result of huge political and other gratuities to Hillary Clinton and The Clinton Foundation, and at Mrs. Clinton's recommendation. During the confirmation process before Congress, Dr. Margaret A. Hamburg, acting in concert with her husband, Peter F. Brown and the other Defendants named in this Amended Complaint, at all material times the Co-CEO of a hedge fund named Renaissance Technologies, L.L.C., failed to disclose to Congress and other relevant authorities, her and her husband's clear-cut conflict of interest – specifically, that Renaissance Technologies, L.L.C. held hundreds of millions of dollars of Johnson & Johnson stock, the manufacturer of the deadly drug, Levaquin.
...Defendant Hamburg, on behalf of all of the Defendants as part of this racketeering conspiracy, gave political contributions and gratuities to Hillary Clinton in 2005, 2006, 2007, and 2008 to induce Mrs. Clinton to recommend and push for Defendant Hamburg to be nominated by President Obama.
...Defendant Hamburg, on behalf of all of the Defendants as part of this racketeering conspiracy, gave political contributions and gratuities to President Obama to induce him to nominate her to be appointed as FDA Commissioner.
From May 2009 to March 2015, Plaintiffs suffered mitochondrial toxicity, neuropsychiatric adverse events, and multi-system disability related to their consumption of Levaquin, including a constellation of medical issues related to the following body systems: neuromuscular, neuropsychiatric, peripheral neuropathy, senses, skin, cardiovascular, plus, endocrine, nutritional, metabolic and immunity; blood and blood forming organs; circulatory system; respiratory system; digestive system; genitourinary system; and connective tissue.
Specifically, Plaintiffs suffer from a constellation of medical issues, including but not limited to widespread bodily pain, fatigue, muscle weakness, muscle twitching, muscle wasting, gait disturbances, severe balance issues, stiffness, spasms, joint pain, tendon issues, seizures, tremors, numbness, burning, tingling, fasciculation, spasticity, nerve damage, autonomic issues, voice issues, exercise intolerance, difficulty swallowing, slow digestive motility, abdominal pain, acid reflux, gastritis, nausea, constipation, diarrhea, colitis, cognitive impairment, memory impairment, cardiac issues, urinary issues, kidney damage, liver damage, pancreatic damage, thyroid abnormalities, hair loss, glucose issues, respiratory issues, emotional issues, depression, psychosis, depersonalization, dissociation, anxiety, insomnia, abnormal dreams, suicidal thoughts, thought alterations, agitation, fatigue, dizziness, inability to concentrate, panic attacks, difficulty communicating, forgetfulness, bruising, vision issues, hearing issues, tinnitus, dental issues, gum issues, skin issues, rashes, multiple chemical sensitivity, sexual dysfunction, reproductive issues, and DNA damage.
Users browsing this forum: No registered users and 1 guest